Author:
Liao Hongyan,Zheng Qin,Jin Yongmei,Chozom Tashi,Zhu Ying,Liu Li,Jiang Nenggang
Abstract
AbstractThis study was aimed to dissect the prognostic significances of hematogones and CD34+ myeloblasts in bone marrow for adult B-cell acute lymphoblastic leukemia(ALL) without minimal residual disease(MRD) after the induction chemotherapy cycle. A total of 113 ALL patients who have received standardized chemotherapy cycle were analyzed. Cases that were not remission after induction chemotherapy or have received stem cell transplantation were excluded. Flow cytometry was used to quantify the levels of hematogones and CD34+ myeloblasts in bone marrow aspirations, and the patients were grouped according to the levels of these two precursor cell types. The long-term relapse-free survival(RFS) and recovery of peripheral blood cells of each group after induction chemotherapy were compared. The results indicated that, after induction chemotherapy, patients with hematogones ≥0.1% have a significantly longer remission period than patients with hematogones <0.1% (p = 0.001). Meanwhile, the level of hematogones was positively associated with the recovery of both hemoglobin and platelet in peripheral blood, while CD34+ myeloblasts level is irrelevant to the recovery of Hb and PLT in peripheral blood, level of hematogones and long-term prognosis. This study confirmed hematogones level after induction chemotherapy can be used as a prognostic factor for ALL without MRD. It is more applicable for evaluation prognosis than CD34+ myeloblasts.
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Faderl, S., Jeha, S. & Kantarjian, H. M. The biology and therapy of adult acute lymphoblastic leukemia. Cancer 98, 1337–54 (2003).
2. Yao, Q. M. et al. Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia. BMC Cancer 11, 269, https://doi.org/10.1186/s12885-016-2300-7 (2016).
3. Aldoss, I. T., Marcucci, G. & Pullarkat, V. Treatment of Acute Lymphoblastic Leukemia in Adults: Applying Lessons Learned in Children. Oncology (Williston Park) 30, 1080–91 (2016).
4. Burke, P. W. & Douer, D. Acute lymphoblastic leukemia in adolescents and young adults. Acta Haematol 132, 264–73 (2014).
5. Chiaretti, S. et al. Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts. Haematologica 98, 1792–10 (2013).
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献